-
Mashup Score: 1Posters - ESMO Congress 2023 - 5 day(s) ago
Marwan Fakih (Duarte, United States of America) We have previously reported significant differences between the tumor immune microenvironm ent (TIME) of primary colorectal cancer (CRC-P) and different metastatic sites. Increased immune cell infiltration, B-cells, and CD8 cells and decreased macrophages were noted in CRC-P and lung metastatic (LuM) lesions compared to liver (LM) and peritoneum (PM) metastases. We expanded our work to MSI CRC and compared their TIME to respective MSS tumor sites. De-identifi
Source: cslide.ctimeetingtech.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8Sarcoma and Rare Cancers 2024 - Sarcoma and Rare Cancers 2024 - 2 month(s) ago
All times are listed in CET (Central European
Source: cslide.ctimeetingtech.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 10ESMO Congress 2023 - Conference Calendar - ESMO Congress 2023 - 7 month(s) ago
This session will not be live-streamed. Participation only onsite. This session will not be live-streamed. Participation only on-site. This session will not be live-streamed. Participation only
Source: cslide.ctimeetingtech.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3ESMO Congress 2023 - Conference Calendar - ESMO Congress 2023 - 7 month(s) ago
Javier Cortés (Madrid, Spain) Mahesh K. Parmar (London, United Kingdom) Ian F. Tannock (Toronto, Canada) Jean-Yves Blay (Lyon, France) Elisabete Weiderpass (Lyon, France) Andrea Ferrari (Milan, Italy) Ivana Bozovic Spasojevic (Belgrade, Serbia) Salvatore Siena (Milan, Italy) Cesar Serrano (Barcelona, Spain) Ignacio Duran Martinez (Santander, Spain) John A. Bridgewater (London, United Kingdom) Esra Urkmez Uzel (Geneva, Switzerland) Virpi Sulosaari (Turku, Finland) Daniel Kelly (Cardiff, United Kingdom)
Source: cslide.ctimeetingtech.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3ESMO Congress 2023 - Conference Calendar - ESMO Congress 2023 - 7 month(s) ago
Javier Cortés (Madrid, Spain) Mahesh K. Parmar (London, United Kingdom) Ian F. Tannock (Toronto, Canada) Jean-Yves Blay (Lyon, France) Elisabete Weiderpass (Lyon, France) Andrea Ferrari (Milan, Italy) Ivana Bozovic Spasojevic (Belgrade, Serbia) Salvatore Siena (Milan, Italy) Cesar Serrano (Barcelona, Spain) Ignacio Duran Martinez (Santander, Spain) John A. Bridgewater (London, United Kingdom) Esra Urkmez Uzel (Geneva, Switzerland) Virpi Sulosaari (Turku, Finland) Daniel Kelly (Cardiff, United Kingdom)
Source: cslide.ctimeetingtech.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4ESMO Congress 2023 - Conference Calendar - ESMO Congress 2023 - 7 month(s) ago
Vivek Subbiah (Nashville, NV, United States of America) Vivek Subbiah (Nashville, NV, United States of America) Vivek Subbiah (Nashville, NV, United States of America) Vivek Subbiah (Nashville, NV, United States of America) Vivek Subbiah (Nashville, NV, United States of America) Javier Hernandez-Losa (Barcelona, Spain) Vivek Subbiah (Nashville, NV, United States of America) Jarushka Naidoo (Dublin, Ireland) Daniel Shao Weng Tan (Singapore, Singapore) Vivek Subbiah (Nashville, NV, United States of
Source: cslide.ctimeetingtech.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2ESMO Congress 2023 - Conference Calendar - ESMO Congress 2023 - 7 month(s) ago
Vivek Subbiah (Nashville, NV, United States of America) Vivek Subbiah (Nashville, NV, United States of America) Vivek Subbiah (Nashville, NV, United States of America) Vivek Subbiah (Nashville, NV, United States of America) Vivek Subbiah (Nashville, NV, United States of America) Javier Hernandez-Losa (Barcelona, Spain) Vivek Subbiah (Nashville, NV, United States of America) Jarushka Naidoo (Dublin, Ireland) Daniel Shao Weng Tan (Singapore, Singapore) Vivek Subbiah (Nashville, NV, United States of
Source: cslide.ctimeetingtech.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1ESMO Congress 2023 - Conference Calendar - ESMO Congress 2023 - 7 month(s) ago
Vivek Subbiah (Nashville, NV, United States of America) Vivek Subbiah (Nashville, NV, United States of America) Vivek Subbiah (Nashville, NV, United States of America) Vivek Subbiah (Nashville, NV, United States of America) Vivek Subbiah (Nashville, NV, United States of America) Javier Hernandez-Losa (Barcelona, Spain) Vivek Subbiah (Nashville, NV, United States of America) Jarushka Naidoo (Dublin, Ireland) Daniel Shao Weng Tan (Singapore, Singapore) Vivek Subbiah (Nashville, NV, United States of
Source: cslide.ctimeetingtech.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Agenda: The Big Bang of Precision Oncology: Creating Milestones in Medicine Link: https://t.co/IdbsSNCiLA Excited to host @javihl75 @DrJNaidoo @danieltanmd @dramoore1 @OncoAlert @KRASKickers as faculty for this @bayer sponsored Satellite Symposium at #ESMO23 👏 Join us for a… https://t.co/v79L5ZEv0u https://t.co/Q8z3J0AcFV
-
-
Mashup Score: 28ESMO Congress 2023 - Conference Calendar - ESMO Congress 2023 - 7 month(s) ago
This session will not be live-streamed. Participation only on-site. This session will not be live-streamed. Participation only
Source: cslide.ctimeetingtech.comCategories: Hem/Oncs, Latest HeadlinesTweet-
In #GU, as well all tracks (took a peek, abstracts released), this is going to be a very busy and rich #ESMO23!! Cannot miss it! @Silke_Gillessen @APassaroMD @AndresC27622123 @KKronig @MyriamChalabi https://t.co/2cgbxhP8yG
-
-
Mashup Score: 1Conference Calendar - The 91st EAS Congress - 12 month(s) ago
The congress will officially run on CET time zone (Central European Time) Legend Plenary (2) (2) Break (2) (2) Industry Session (2) (2) CME Session (2) (2) Hall:…
Source: cslide.ctimeetingtech.comCategories: Cardiologists, Latest HeadlinesTweet
Comparative analysis of the tumor immune microenvironment (TIME) in primary & metastatic sites of microsatellite stable (MSS) & microsatellite instability-high (MSI) colorectal cancer [10/22/23] @mgfakih et al @jgong15 #ESMO23 Abst 574P https://t.co/O99AmGH1hT #crcsm #ImmunoOnc